Index RUT
P/E -
EPS (ttm) -0.13
Insider Own 3.97%
Shs Outstand 5.37M
Perf Week 17.59%
Market Cap 541.10M
Forward P/E 12.49
EPS next Y 8.04
Insider Trans -4.04%
Shs Float 5.18M
Perf Month 7.58%
Income -0.72M
PEG -
EPS next Q 1.78
Inst Own 91.28%
Short Float / Ratio 5.67% / 6.90
Perf Quarter -18.21%
Sales 213.69M
P/S 2.53
EPS this Y -14.97%
Inst Trans -1.59%
Short Interest 0.29M
Perf Half Y -24.73%
Book/sh 72.22
P/B 1.39
EPS next Y 13.46%
ROA -0.11%
Target Price 115.00
Perf Year -42.22%
Cash/sh 6.61
P/C 15.19
EPS next 5Y -
ROE -0.19%
52W Range 82.86 - 206.36
Perf YTD -39.60%
Dividend 0.64
P/FCF 14.88
EPS past 5Y -
ROI -0.13%
52W High -51.35%
Beta 0.75
Dividend % 0.64%
Quick Ratio 2.13
Sales past 5Y 18.33%
Gross Margin 50.23%
52W Low 21.16%
ATR 5.00
Employees 698
Current Ratio 2.96
Sales Q/Q -9.50%
Oper. Margin 1.56%
RSI (14) 61.08
Volatility 6.09% 5.49%
Optionable No
Debt/Eq 0.45
EPS Q/Q -193.76%
Profit Margin -0.34%
Rel Volume 1.19
Prev Close 95.04
Shortable Yes
LT Debt/Eq 0.44
Earnings Nov 06 BMO
Payout 368.88%
Avg Volume 42.61K
Price 100.39
Recom 2.33
SMA20 11.64%
SMA50 5.23%
SMA200 -24.99%
Volume 50,886
Change 5.63%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-04-21 Downgrade
Evercore ISI
Outperform → In-line
$300
Nov-10-20 Initiated
KeyBanc Capital Markets
Sector Weight
$287
Oct-02-20 Initiated
JP Morgan
Neutral
$260
Dec-04-19 Initiated
Jefferies
Buy
Aug-26-19 Initiated
Evercore ISI
Outperform
$250
Jun-10-16 Downgrade
Sidoti
Buy → Neutral
Nov-06-23 09:10AM
08:13AM
(Associated Press Finance)
08:00AM
Oct-16-23 03:00AM
Oct-03-23 08:00AM
08:09AM
Loading…
Sep-22-23 08:09AM
06:20AM
Sep-15-23 01:10AM
Sep-13-23 01:37PM
Sep-11-23 11:21AM
Aug-24-23 04:02PM
Aug-10-23 01:32AM
Aug-03-23 09:35AM
08:27AM
08:00AM
07:50AM
Loading…
Jul-31-23 07:50AM
Jul-05-23 03:00PM
Jun-21-23 08:00PM
11:50AM
May-25-23 09:25AM
08:14AM
08:00AM
May-22-23 01:16PM
May-02-23 06:23AM
Apr-26-23 08:00PM
Apr-03-23 06:15PM
06:00PM
07:42AM
Mar-13-23 08:00AM
Mar-09-23 08:00AM
05:36AM
Loading…
Feb-21-23 05:36AM
Feb-14-23 09:00AM
Feb-13-23 12:45PM
08:00AM
Feb-06-23 09:55AM
08:36AM
Feb-01-23 12:43PM
06:43AM
Jan-27-23 06:00PM
Jan-19-23 06:15PM
Jan-17-23 04:33PM
Jan-13-23 06:00PM
Jan-12-23 09:40AM
Jan-11-23 06:26AM
Jan-09-23 06:15PM
Jan-03-23 05:00PM
Dec-28-22 06:51AM
05:20AM
Dec-18-22 04:48PM
Dec-16-22 11:59AM
Nov-23-22 12:20PM
Nov-17-22 08:04AM
Nov-08-22 06:48AM
Nov-04-22 03:49PM
Nov-03-22 10:25AM
08:00AM
Oct-25-22 06:32AM
Oct-03-22 02:00PM
Sep-11-22 08:33AM
Aug-04-22 11:05AM
08:00AM
Jul-28-22 10:03AM
Jul-06-22 07:00PM
Jun-27-22 08:01AM
May-31-22 09:25AM
08:00AM
May-13-22 10:17AM
Apr-12-22 09:51AM
Apr-06-22 01:10PM
Apr-04-22 12:02PM
Feb-03-22 09:25AM
09:11AM
08:00AM
Jan-26-22 03:01PM
Jan-06-22 03:00PM
Dec-21-21 08:01AM
07:12AM
Dec-20-21 12:48PM
07:52AM
Dec-16-21 10:47AM
05:20AM
Dec-11-21 09:15AM
Nov-04-21 10:55AM
08:00AM
Oct-29-21 08:00AM
Oct-28-21 03:05PM
Oct-21-21 09:35AM
Oct-20-21 12:05PM
Oct-08-21 05:48AM
05:20AM
Oct-01-21 03:00PM
Sep-14-21 01:02PM
07:50AM
07:00AM
Sep-13-21 11:49AM
Aug-22-21 10:38AM
Aug-05-21 11:15AM
08:00AM
Jul-29-21 03:05PM
Jul-08-21 04:54AM
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Instruments, Continuous Monitoring, and Biopharmaceutical Development. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Instrument segment designs, manufactures, and markets control instruments and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. The Biopharmaceutical Development segment develops and sells automated systems for protein analysis and peptide synthesis solutions. The Continuous Monitoring segment includes development of systems used to monitor various environmental parameters. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Schmieder John Bradley Director Sep 15 Sale 123.74 1,000 123,740 62,760 Sep 19 12:34 PM Schmieder John Bradley Director Sep 14 Sale 123.05 3,000 369,150 63,760 Sep 19 12:34 PM Schmieder John Bradley Director Sep 13 Sale 123.32 3,000 369,965 66,760 Sep 14 01:47 PM Owens Gary M President and CEO Sep 01 Option Exercise 136.42 2,000 272,840 32,032 Sep 05 04:34 PM Owens Gary M President and CEO Sep 01 Sale 142.82 2,000 285,640 30,032 Sep 05 04:34 PM Tripeny R Tony Director Aug 15 Option Exercise 0.00 1,105 0 1,605 Aug 16 03:54 PM Ladiwala Shiraz Shabanali Director Aug 15 Option Exercise 0.00 1,055 0 1,460 Aug 16 03:45 PM Ladiwala Shiraz Shabanali Director Aug 15 Option Exercise 0.00 40 0 1,500 Sep 06 12:36 PM Sullivan John James Director Aug 15 Option Exercise 0.00 754 0 29,004 Aug 16 03:37 PM Alltoft Jennifer Sadie Director Aug 15 Option Exercise 0.00 754 0 2,400 Aug 16 03:28 PM Schmieder John Bradley Director Aug 15 Option Exercise 0.00 754 0 69,760 Aug 16 03:19 PM Hall Shannon Director Aug 15 Option Exercise 0.00 754 0 1,711 Aug 16 02:03 PM Owens Gary M President and CEO Jun 16 Option Exercise 0.00 2,820 0 30,992 Jun 21 01:22 PM Archbold Brian David SVP Operations Jun 16 Option Exercise 0.00 612 0 2,247 Jun 21 12:23 PM Sakys John CFO Jun 16 Option Exercise 0.00 848 0 11,019 Jun 21 12:02 PM Sullivan John James Director Jun 16 Option Exercise 0.00 15 0 28,256 Jun 21 01:38 PM Schmieder John Bradley Director Jun 15 Option Exercise 0.00 30 0 69,006 Jun 16 07:46 PM Owens Gary M CEO Jun 15 Option Exercise 0.00 2,823 0 29,409 Jun 16 07:37 PM Archbold Brian David SVP Operations Jun 15 Option Exercise 0.00 614 0 1,918 Jun 16 07:10 PM Sakys John CFO Jun 15 Option Exercise 0.00 848 0 10,544 Jun 16 06:24 PM Sullivan John James Director Jun 15 Option Exercise 0.00 15 0 28,247 Jun 16 07:56 PM Sakys John CFO Mar 24 Option Exercise 85.13 2,128 181,147 10,824 Mar 27 09:40 AM Sakys John CFO Mar 24 Sale 167.01 2,128 355,397 9,696 Mar 27 09:40 AM Sakys John CFO Mar 22 Option Exercise 122.66 2,500 306,650 12,196 Mar 27 09:40 AM Sakys John CFO Mar 22 Sale 171.62 2,500 429,050 9,696 Mar 27 09:40 AM Sakys John CFO Mar 15 Option Exercise 70.56 1,000 70,560 10,696 Mar 16 02:42 PM Sakys John CFO Mar 15 Sale 165.71 1,000 165,710 9,696 Mar 16 02:42 PM Sakys John CFO Mar 09 Option Exercise 70.56 400 28,224 10,096 Mar 09 06:13 PM Sakys John CFO Mar 09 Sale 169.97 400 67,988 9,696 Mar 09 06:13 PM Sakys John CFO Feb 09 Option Exercise 51.85 1,000 51,850 10,696 Feb 09 08:04 PM Sakys John CFO Feb 09 Sale 184.27 1,000 184,270 9,696 Feb 09 08:04 PM Sakys John CFO Jan 23 Option Exercise 70.56 2,100 148,176 11,796 Jan 25 12:23 PM Sakys John CFO Jan 23 Sale 210.19 2,100 441,399 9,696 Jan 25 12:23 PM Schmieder John Bradley Director Jan 13 Sale 191.31 1,571 300,548 68,976 Jan 17 10:52 AM Hall Shannon Director Dec 08 Sale 174.97 230 40,244 957 Dec 09 09:00 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite